Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Robert D. Fishberg"'
Publikováno v:
American Journal of Preventive Cardiology, Vol 13, Iss , Pp 100405- (2023)
Therapeutic Area: ASCVD/CVD Risk Assessment Background: Like Familial Hypercholesterolemia (FH), Lp(a) ≥300nmol/L is associated with 3-4-fold increased cardiovascular risk but is more common. Cascade screening of first-degree relatives for FH has b
Externí odkaz:
https://doaj.org/article/1271c1c28bf44f569a1b539721b25955
Publikováno v:
American Journal of Preventive Cardiology, Vol 13, Iss , Pp 100406- (2023)
Therapeutic Area: ASCVD/CVD Risk Assessment Background: FH affects 1:250 and Lp(a) ≥300 nmol/L affects 1:50 individuals; each associated with ∼3x risk of MACE according to the SAFEHEART trial. Furthermore, the combination of both FH and elevated
Externí odkaz:
https://doaj.org/article/25c097780c414262817c616f0defd383
Publikováno v:
Cureus.
Publikováno v:
Journal of the American College of Cardiology. 81:95
Publikováno v:
Journal of the American College of Cardiology. 81:3313
Publikováno v:
World Journal of Cardiology
Background Eosinophilic granulomatosis polyangiitis (EGPA) is a small vessel necrotizing vasculitis that commonly presents as peripheral eosinophilia and asthma; however, it can rarely manifest with cardiac involvement such as pericarditis and cardia
Publikováno v:
Circulation. 144
Introduction: The EDACS-ADP risk score includes 12-lead electrocardiogram (ECG) and troponin (cTn) to stratify patients presenting with chest pain. The ECG can be derived (dECG) from 3 measured leads with high correlation. A new cardiac electrical bi
Publikováno v:
Journal of the American College of Cardiology. 79:3252
Publikováno v:
Journal of the American College of Cardiology. 79:2374
Publikováno v:
Journal of the American College of Cardiology. 79:143